BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29577367)

  • 1. Bioluminescence-driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model.
    Zenchak JR; Palmateer B; Dorka N; Brown TM; Wagner LM; Medendorp WE; Petersen ED; Prakash M; Hochgeschwender U
    J Neurosci Res; 2020 Mar; 98(3):458-468. PubMed ID: 29577367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BioLuminescent-OptoGenetic in vivo response to coelenterazine is proportional, sensitive, and specific in neocortex.
    Gomez-Ramirez M; More AI; Friedman NG; Hochgeschwender U; Moore CI
    J Neurosci Res; 2020 Mar; 98(3):471-480. PubMed ID: 31544973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optochemogenetic Stimulation of Transplanted iPS-NPCs Enhances Neuronal Repair and Functional Recovery after Ischemic Stroke.
    Yu SP; Tung JK; Wei ZZ; Chen D; Berglund K; Zhong W; Zhang JY; Gu X; Song M; Gross RE; Lin SZ; Wei L
    J Neurosci; 2019 Aug; 39(33):6571-6594. PubMed ID: 31263065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved trafficking and expression of luminopsins for more efficient optical and pharmacological control of neuronal activity.
    Zhang JY; Tung JK; Wang Z; Yu SP; Gross RE; Wei L; Berglund K
    J Neurosci Res; 2020 Mar; 98(3):481-490. PubMed ID: 31670406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Locomotor Recovery in a Rat Model of Spinal Cord Injury by BioLuminescent-OptoGenetic (BL-OG) Stimulation with an Enhanced Luminopsin.
    Ikefuama EC; Kendziorski GE; Anderson K; Shafau L; Prakash M; Hochgeschwender U; Petersen ED
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioluminescent Optogenetics: A Novel Experimental Therapy to Promote Axon Regeneration after Peripheral Nerve Injury.
    English AW; Berglund K; Carrasco D; Goebel K; Gross RE; Isaacson R; Mistretta OC; Wynans C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of neurological dysfunctions in aphakia mice, a model of Parkinson's disease, after transplantation of ES cell-derived dopaminergic neuronal precursors.
    Chung S; Moon J; Kim KS
    Methods Mol Biol; 2014; 1213():285-91. PubMed ID: 25173391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining parameters of specificity for bioluminescent optogenetic activation of neurons using in vitro multi electrode arrays (MEA).
    Prakash M; Medendorp WE; Hochgeschwender U
    J Neurosci Res; 2020 Mar; 98(3):437-447. PubMed ID: 30152529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.
    Moon J; Lee HS; Kang JM; Park J; Leung A; Hong S; Chung S; Kim KS
    Cell Transplant; 2013; 22(7):1263-79. PubMed ID: 23031199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural stem cells transplanted in a mouse model of Parkinson's disease differentiate to neuronal phenotypes and reduce rotational deficit.
    Ziavra D; Makri G; Giompres P; Taraviras S; Thomaidou D; Matsas R; Mitsacos A; Kouvelas ED
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):829-35. PubMed ID: 23131156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Optogenetic and Chemogenetic Control of Neurons.
    Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
    Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motoneuron activity is required for enhancements in functional recovery after peripheral nerve injury in exercised female mice.
    Jaiswal PB; Tung JK; Gross RE; English AW
    J Neurosci Res; 2020 Mar; 98(3):448-457. PubMed ID: 28771790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model.
    Tønnesen J; Parish CL; Sørensen AT; Andersson A; Lundberg C; Deisseroth K; Arenas E; Lindvall O; Kokaia M
    PLoS One; 2011 Mar; 6(3):e17560. PubMed ID: 21394212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo visualization and monitoring of viable neural stem cells using noninvasive bioluminescence imaging in the 6-hydroxydopamine-induced mouse model of Parkinson disease.
    Im HJ; Hwang DW; Lee HK; Jang J; Lee S; Youn H; Jin Y; Kim SU; Kim EE; Kim YS; Lee DS
    Mol Imaging; 2013 Jun; 12(4):224-34. PubMed ID: 23651500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
    Ramos-Moreno T; Castillo CG; Martínez-Serrano A
    Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model.
    Steinbeck JA; Choi SJ; Mrejeru A; Ganat Y; Deisseroth K; Sulzer D; Mosharov EV; Studer L
    Nat Biotechnol; 2015 Feb; 33(2):204-9. PubMed ID: 25580598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Step-function luminopsins for bimodal prolonged neuromodulation.
    Berglund K; Fernandez AM; Gutekunst CN; Hochgeschwender U; Gross RE
    J Neurosci Res; 2020 Mar; 98(3):422-436. PubMed ID: 30957296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.